ECTRIMS 2024 Insights: Clinical Spectrum of MOG Antibody-Associated …

Kazuo Fujihara

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

Dominika Stastna

ECTRIMS 2024 Insights: Pathology of NMOSD, MOGAD and MS

Hans Lassmann

Management of Neuromyelitis Optica Spectrum Disorders (NMOSD) in 2022

University of Miami

L. Tornes

The Role of Optical Coherence Tomography in Neurology

University of Miami

H. Jiang

Optical Coherence Tomography (OCT) in Neuromyelitis Optica Spectrum …

University of Miami

H. Jiang

Anti-C5 Complement Therapy in NMO: Eculizumab and Ravulizumab

University of Miami

F. Nelson

Imaging Features of MOGAD and Key Flags

Giulia Fadda

Immune Checkpoint Inhibitors and Neurological Adverse Events

Cleveland Clinic Neurological Institute

A. Kunchok

Neuroimaging Case Studies in Inflammation and Demyelination

2023 Conference Coverage

U. Kaunzner

Cases of Caution in Inpatient Neuroimmunology: When the First Diagno…

Northwestern Medicine Neurology and Neurosurgery

E. Graham

Diagnostic Criteria for Myelin Oligodendrocyte Glycoprotein Antibody…

Cleveland Clinic Neurological Institute

J. R. Abbatemarco

Neuromyelitis Optica: Acute and Preventative Treatments in the Era o…

Bruce Cree

Iatrogenic CNS Inflammation in the Era of Modern Biologics

University Hospitals

H. Abboud

Everything a Neurologist Needs to Know About NMO & MOG

University of Miami

M. Levy

Update in Autoimmune Neurology & Neuroimmunology

Justin R. Abbatemarco

The Current Spectrum of NMOSD

Olga Rosenvald Thon

MOG Antibody Disease (MOGAD) Update

University of Miami

M. Ortega

Challenges of Neurological Presentations in Rheumatic Diseases: Lab …

McMaster University Department of Medicine

E. Shosha

Diagnostic Criteria and Biomarkers on the Horizon (MRI, OCT, Blood)

Cedars Sinai

O. Al-Louzi